Comparing the Use and Survival Outcome of Stereotactic Radiosurgery and Stereotactic Radiation Therapy

Title

Comparing the Use and Survival Outcome of Stereotactic Radiosurgery and Stereotactic Radiation Therapy

Files

Download Garett Ostdiek-Wille Original Presentation File (131 KB)

Loading...

Media is loading
 

Publication Date

Summer 8-6-2020

College, Institute, or Department

Radiation Oncology

Faculty Mentor

Chi Lin

Research Mentor

Shuo Wang

Document Type

Poster

Abstract

Brain metastases are common in many types of cancer. Treatment for this condition is usually through surgical resection, whole brain radiation treatment (WBRT), stereotactic radiosurgery (SRS), or stereotactic radiation therapy (SRT). SRS (15 to 24 Gy in 1 fraction) and SRT (21, 24 or 30 Gy in 3 fractions or 25, 30 Gy in 5 fractions) have similar biological equivalent doses but differ in the number of treatments the radiation is delivered over. The objective of this study is to use national cancer database (NCDB) to examine the factors associated with receiving SRS as compared to SRT, and to compare overall survival between patients who received SRS to those who received SRT after adjusting for all potential prognostic factors. The two treatments were not found to have a significant difference in survival.

Keywords

Cancer, radiosurgery, radiation treatment

Comparing the Use and Survival Outcome of Stereotactic Radiosurgery and Stereotactic Radiation Therapy

Share

COinS